213 related articles for article (PubMed ID: 18757406)
1. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
[TBL] [Abstract][Full Text] [Related]
2. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
Castro-Rivera E; Ran S; Brekken RA; Minna JD
Cancer Res; 2008 Oct; 68(20):8295-303. PubMed ID: 18922901
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
Bielenberg DR; Shimizu A; Klagsbrun M
Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022
[TBL] [Abstract][Full Text] [Related]
5. Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis.
Mumblat Y; Kessler O; Ilan N; Neufeld G
Cancer Res; 2015 Jun; 75(11):2177-86. PubMed ID: 25808871
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Joseph D; Ho SM; Syed V
Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin-3F is an inhibitor of tumor angiogenesis.
Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
[TBL] [Abstract][Full Text] [Related]
10. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
12. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.
Castro-Rivera E; Ran S; Thorpe P; Minna JD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11432-7. PubMed ID: 15273288
[TBL] [Abstract][Full Text] [Related]
14. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
[TBL] [Abstract][Full Text] [Related]
15. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
16. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I.
Beecken WD; Engl T; Ringel EM; Camphausen K; Michaelis M; Jonas D; Folkman J; Shing Y; Blaheta RA
Ann Surg Oncol; 2006 Sep; 13(9):1241-51. PubMed ID: 16955386
[TBL] [Abstract][Full Text] [Related]
17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F.
Guo HF; Li X; Parker MW; Waltenberger J; Becker PM; Vander Kooi CW
Biochemistry; 2013 Oct; 52(43):7551-8. PubMed ID: 24079887
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic activity of a concentrated effective microorganism fermentation extract.
Chui CH; Gambari R; Lau FY; Hau DK; Wong RS; Cheng GY; Kok SH; Higa T; Ke B; Chan AS; Fong DW; Tang JC
Int J Mol Med; 2006 Nov; 18(5):975-9. PubMed ID: 17016630
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A.
Hong S; Chang SY; Yeom DH; Kang JH; Hong KJ
Anticancer Drugs; 2007 Oct; 18(9):1005-14. PubMed ID: 17704650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]